The epitopes of MSLN peptides, specifically tailored for cytotoxic T lymphocytes (CTLs) clones, shared sequences previously demonstrated to exert an anti-tumor effect against MSLN-expressing malignant pleural mesothelioma [56] and pancreatic cancer cells [57]. The gene discussed is MSLN; the disease is pancreatic neoplasm.